El-Chami Mikhael F, Cunnane Ryan
Division of Cardiology, Section of Electrophysiology, Emory University School of Medicine, 550 Peachtree Street, NE Atlanta, GA 30308, USA.
Division of Cardiology, Section of Electrophysiology, University of Michigan, Ann Arbor, MI, USA.
Eur Heart J Suppl. 2025 Mar 24;27(Suppl 2):ii21-ii25. doi: 10.1093/eurheartjsupp/suae093. eCollection 2025 Mar.
Leadless pacemakers' (LPs) main advantage over the traditional transvenous permanent pacemakers (TV-PPMs) is the absence of leads and subcutaneous pocket. These intracardiac pacemakers have been shown in observational studies to reduce long-term complications as compared with TV-PPM mainly by reducing the need for re-intervention. Two major advantages of this technology are the lower rate of infection (absence of pocket and lower rate of bacterial seeding) and lead-related complications (dislodgment). Hence, these advantages are more accentuated after transcutaneous valve replacement or valve surgery and clinical situations where it is important to reduce systemic infections and endocarditis. In this review, we highlight the role of LP in patients after transcutaneous and surgical valve replacements.
无导线起搏器（LPs）相较于传统经静脉永久起搏器（TV-PPMs）的主要优势在于无需导线和皮下囊袋。观察性研究表明，与TV-PPM相比，这些心内起搏器主要通过减少再次干预的需求来降低长期并发症。这项技术的两大主要优势是感染率较低（无囊袋且细菌植入率较低）以及与导线相关的并发症（导线移位）。因此，在经皮瓣膜置换或瓣膜手术后以及在减少全身感染和心内膜炎至关重要的临床情况下，这些优势更为突出。在本综述中，我们重点介绍了无导线起搏器在经皮和外科瓣膜置换术后患者中的作用。
